+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Angiotensin Receptor Agonist"

Angiotensin Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Angiotensin Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

The Angiotensin Receptor Agonist market is a subset of the Cardiovascular Drugs market. Angiotensin Receptor Agonists are drugs used to treat hypertension, heart failure, and other cardiovascular conditions. These drugs work by activating the angiotensin receptor, which helps to regulate blood pressure. Angiotensin Receptor Agonists are typically prescribed in combination with other drugs, such as diuretics, to help reduce blood pressure. They are also used to reduce the risk of stroke and heart attack. The Angiotensin Receptor Agonist market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Novartis, Merck, Pfizer, Sanofi, and AstraZeneca. These companies offer a range of products, including generic and branded drugs, to meet the needs of patients. Show Less Read more